Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]
NCT00214110
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG:
Tamoxifen
Sponsor
University of Wisconsin, Madison